Authors


Kristine L. Funk, MS

Latest:

Do Patient or Provider Characteristics Impact Management of Diabetes?

Many more patient than provider characteristics are associated with optimal or poor glycemic control and treatment intensification when glycemic control is initially lost.


Om P. Ganda, MD, Chair, Clinical Oversight Committee

Latest:

CHAPTER 5. Clinical Guideline for Pharmacological Management of Adults With Type 2 Diabetes

From the Adult Diabetes and Clinical Research Sections, Joslin Diabetes Center, Harvard Medical School. Approved May 10, 2016; updated April 24, 2018. For the Figure and Tables, download the PDF at the end of the chapter.


Anne C. Lambert-Kerzner, MSPH

Latest:

A Multimodal Blood Pressure Control Intervention in 3 Healthcare Systems

A multisite multimodal intervention of patient education, home monitoring, measurement reporting to an IVR system, and pharmacist follow-up achieved greater BP reductions vs usual care.


Kailey Love, MBA, MS

Latest:

Patient Assignment and Quality Performance: A Misaligned System

This article explores the congruence between payer patient assignment and quality performance and the implications for incentive payments in alternative payment models.



Erin R. Giovannetti, PhD

Latest:

Performance Measurement for People With Multiple Chronic Conditions: Conceptual Model

The Performance Measurement for People with Multiple Chronic Conditions conceptual model can facilitate development and refinement of quality measures for a medically complex population.


Christine A. Sinsky, MD

Latest:

Lessons From CareMore: A Stepping Stone to Stronger Primary Care of Frail Elderly Patients

CareMore, an insurance plan based in southern California, has reduced costs and improved outcomes by providing direct care for its frailest elderly patients.



Sumesh Kachroo, PhD

Latest:

Oral Anticoagulant Discontinuation in Patients With Nonvalvular Atrial Fibrillation

The risk of discontinuation of oral anticoagulant therapy (both warfarin and direct oral anticoagulant therapies [DOACs]) among nonvalvular atrial fibrillation patients was high. Although the hazard ratio for discontinuation favors DOACs, it is unlikely that the small difference in discontinuation relative to warfarin is clinically meaningful.


Justin Kanter, MA

Latest:

Delivering on the Value Proposition of Precision Medicine: The View From Healthcare Payers

Genomics-based precision medicine has the potential to transform healthcare delivery. However, effective collaborations among scientists, clinicians, and payers are needed to accelerate the translation of precision medicine to clinical practice and ensure its sustainability.


Mark T. Linthicum, MPP

Latest:

Costs and Spillover Effects of Private Insurers' Coverage of Hepatitis C Treatment

Expanding private-payer coverage of hepatitis C treatment may yield significant long-term cost savings for private payers, reduced costs to Medicare, and increased social value.



David Ratz, MS

Latest:

Measuring Patient-Centered Medical Home Access and Continuity in Clinics With Part-Time Clinicians

Commonly used measures of performance for assessing patient access do not reflect PCMH-encouraged strategies to improve access that may be preferentially used by part-time physicians.


Kevin B. Gregory, BS

Latest:

Insomnia Risks and Costs: Health, Safety, and Quality of Life

This review article discusses the issues surrounding the risks and costs of sleep disturbance as they relate to society and the individual.


Alfred B. Engelberg, JD

Latest:

Have Prescription Drug Brand Names Become Generic?

Prescription drug brand names no longer function as trademarks. They have become the common names of generic versions of the medicine.


Kate A. Stewart, PhD, MS

Latest:

Care Coordination for Children With Special Needs in Medicaid: Lessons From Medicare

As increasing numbers of children with special healthcare needs move into Medicaid managed care, health plans can improve care coordination using evidence from Medicare.


Jack Mardekian, PhD

Latest:

Molecular Testing Patterns in Metastatic Non—Small Cell Lung Cancer

Assessment of the timing of histologic and molecular testing indicates that testing occurred prior to treatment initiation for most patients with metastatic non—small cell lung cancer.



Dwight E. Fox, DMD

Latest:

Office Manager and Nurse Perspectives on Facilitators of Adult Immunization

Factors significantly associated with adult vaccination rates in primary care practices were patients’ age, race, scheduled well-visit length, and nurses’ vaccination status.


Scott A. Davis, MA

Latest:

The Duration of Office Visits in the United States, 1993 to 2010

Nationally representative data show that outpatient office visits to both primary care physicians and specialists grew longer over the period from 1993 to 2010.



Peter B. Bach, MD, MAPP

Latest:

Three Proposals to Reform the 340B Drug Discount Program

The 340B Drug Discount Program has rapidly expanded over the last few years and may be missing its original intent. Here are 3 possible steps that could enhance the program’s function and mirror Congress’ original intent to enhance access for the poor to essential medical services.


Jessica L. Waddell, MPH

Latest:

Cost Sharing, Adherence, and Health Outcomes in Patients With Diabetes

Higher cost-sharing levels reduced adherence to antidiabetic medications in patients with type 2 diabetes.



Mark Panna, MD

Latest:

Electronic Consults for Improving Specialty Care Access for Veterans

The combination of electronic consultations and active triage of specialty care consults effectively reduces wait times for outpatient clinics.


Sarah Beaton, PhD

Latest:

Are Benefits From Diabetes Self-Management Education Sustained?

Conventional individualized diabetes self-management education resulted in sustained improvement in self-efficacy and diabetes distress. Short-term improvements in A1C, nutrition, and physical activity were not sustained.



Jeffrey T. Lee, PhD

Latest:

Cost-Effectiveness of Laparoscopic Gastric Banding and Bypass for Morbid Obesity

Laparoscopic adjustable gastric banding and gastric bypass are cost-effective treatments for morbid obesity compared with no treatment.



AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo